SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012669
Filing Date
2022-08-08
Accepted
2022-08-08 17:21:10
Documents
76
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcel-20220630x10q.htm   iXBRL 10-Q 2153746
2 EX-10.1 bcel-20220630xex10d1.htm EX-10.1 495537
3 EX-31.1 bcel-20220630xex31d1.htm EX-31.1 12779
4 EX-31.2 bcel-20220630xex31d2.htm EX-31.2 12363
5 EX-32.1 bcel-20220630xex32d1.htm EX-32.1 8218
  Complete submission text file 0001558370-22-012669.txt   8104939

Data Files

Seq Description Document Type Size
6 EX-101.SCH bcel-20220630.xsd EX-101.SCH 46662
7 EX-101.CAL bcel-20220630_cal.xml EX-101.CAL 47798
8 EX-101.DEF bcel-20220630_def.xml EX-101.DEF 219426
9 EX-101.LAB bcel-20220630_lab.xml EX-101.LAB 371067
10 EX-101.PRE bcel-20220630_pre.xml EX-101.PRE 340050
70 EXTRACTED XBRL INSTANCE DOCUMENT bcel-20220630x10q_htm.xml XML 1292993
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-595-2595
Atreca, Inc. (Filer) CIK: 0001532346 (see all company filings)

IRS No.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38935 | Film No.: 221145507
SIC: 2834 Pharmaceutical Preparations